Sign inGet started

McLaughlin Gerald W.

Insider CIK 1495412 · PATH VP, Commercial Operations · AYTU Director · NEOS Chief Executive Officer, Director · NMUS Director · ALLR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALLR Allarity Therapeutics, Inc A Award2026-01-282026-05-0745,000— $070,000SEC↗
ALLR Allarity Therapeutics, Inc A Award deriv2025-01-222025-01-2425,000— $025,000SEC↗
ALLR Allarity Therapeutics, Inc A Award deriv2025-01-222025-01-2425,000— $025,000SEC↗
AYTU AYTU BIOPHARMA, INC A Award2021-04-082021-04-126,500— $031,401SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-1965,447— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-19100,000— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-19395,000— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-19600,000— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-19392,688— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer2021-03-192021-03-19270,171— $00SEC↗
NEOS Neos Therapeutics, Inc. F Tax w/h2021-03-022021-03-1644,329$0.84 $37.2K270,171SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2020-03-132020-03-16100,000— $0100,000SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2020-03-132020-03-1665,447— $065,447SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2020-03-022020-03-04395,000— $0395,000SEC↗
NEOS Neos Therapeutics, Inc. A Award2020-03-022020-03-04290,000— $0314,500SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2019-03-012019-03-04523,583— $0523,583SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2019-03-012019-03-22392,688— $0392,688SEC↗
NEOS Neos Therapeutics, Inc. P Buy2018-12-062018-12-1017,097$2.11 $36.1K24,500SEC↗
NEOS Neos Therapeutics, Inc. P Buy2018-12-042018-12-077,403$2.04 $15.1K7,403SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2018-06-272018-06-28600,000— $0600,000SEC↗
NMUS Nemus Bioscience, Inc. A Award2015-10-202015-10-2230,000— $061,250SEC↗
NMUS Nemus Bioscience, Inc. C Conversion deriv2015-08-202015-08-2410,000— $00SEC↗
NMUS Nemus Bioscience, Inc. C Conversion2015-08-202015-08-2431,250— $031,250SEC↗
NMUS Nemus Bioscience, Inc. P Buy deriv2015-05-292015-06-022,000— $02,000SEC↗
NMUS Nemus Bioscience, Inc. P Buy deriv2015-05-292015-06-0210,000$2.50 $25.0K10,000SEC↗
NMUS Nemus Bioscience, Inc. A Award deriv2014-12-042014-12-0820,000— $020,000SEC↗
PATH NUPATHE INC. D To issuer deriv2014-02-212014-02-2557,054$4.88 $278.4K0SEC↗
PATH NUPATHE INC. D To issuer deriv2014-02-212014-02-255,988$4.88 $29.2K0SEC↗
PATH NUPATHE INC. D To issuer deriv2014-02-212014-02-2522,707$5.36 $121.7K0SEC↗
PATH NUPATHE INC. U Tender2014-02-212014-02-2511,771$6.80 $80.0K0SEC↗
PATH NUPATHE INC. D To issuer2014-02-212014-02-25144,880$6.80 $985.2K0SEC↗
PATH NUPATHE INC. A Award2013-01-172013-01-22125,000— $0156,651SEC↗
PATH NUPATHE INC. D To issuer deriv2013-01-072013-01-0916,219— $00SEC↗
PATH NUPATHE INC. D To issuer deriv2013-01-072013-01-0932,850— $00SEC↗
PATH NUPATHE INC. A Award2013-01-072013-01-0923,542— $031,651SEC↗
PATH NUPATHE INC. A Award2013-01-072013-01-098,109— $08,109SEC↗
PATH NUPATHE INC. A Award deriv2012-03-082012-03-2732,850— $032,850SEC↗